Rosetta Capital
Overview
Rosetta Capital is a specialist venture capital firm focused on the life science and medical technology sectors.
Investment Focus
- Companies in late-preclinical or clinical stages of development
- Developing innovative therapeutics, medical devices, or diagnostics
- Potential to transform medical care
- Located across Europe, North America, and Asia
Portfolio Companies
Reach Rosetta Capital directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Rosetta Capital
What sectors does Rosetta Capital invest in?
Rosetta Capital invests in Healthcare, Life Sciences, Pharmaceuticals, Medical Devices, Diagnostics and Biotechnology, and is based in England, United Kingdom. Rosetta Capital is listed as a vc in the ConnectSafely investor database.
What stage does Rosetta Capital invest at?
Rosetta Capital backs companies at Seed, Early Stage, Growth and Late Stage, writing cheques of 5M - 50M.
Which regions does Rosetta Capital invest in?
Rosetta Capital invests across United States, United Kingdom, Canada, Germany, Japan and Australia.
Who are the partners at Rosetta Capital?
Team members listed for Rosetta Capital include Matthew James (Chief Financial Officer) and Jonathan Hepple (Managing Partner).
What companies has Rosetta Capital invested in?
Rosetta Capital's portfolio includes Ceres Media, Crescendo Biologics, Bioventus, F2G, Acacia Pharma, Arecor, Celltech Pharma and Faron Pharmaceuticals.
How do I contact Rosetta Capital?
Rosetta Capital's contact details are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
